newsfilter
← Latest News
Business Wire·

BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26

  • BeOne Medicines Ltd. (NASDAQ: ONC, HKEX: 06160, SSE: 688235) will report fourth quarter & full year 2025 financial results on Thursday, February 26, 2026, before market open.
  • Management will host a live webcast at 8:00 a.m. ET following the financial release.
  • The webcast is accessible via the investors section of the company website at https://ir.beonemedicines.com, with registration recommended 15 minutes prior to start.
  • An archived version of the webcast will be available on the company website.
  • BeOne Medicines is a Switzerland-domiciled global oncology company with a pipeline covering hematology & solid tumors.
  • The company employs nearly 12,000 colleagues across six continents focused on developing novel therapeutics.
  • The press release includes forward-looking statements subject to risks outlined in the company's SEC filings.
  • Investor contact is Liza Heapes at +1 857-302-5663 or ir@beonemed.com.
  • Media contact is Kyle Blankenship at +1 667-351-5176 or media@beonemed.com.